Login / Signup

Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study.

Chongsheng ChengWenshuai XuYani WangTengyue ZhangLuning YangWangji ZhouDanjing HuYanli YangXinlun TianKai-Feng Xu
Published in: Orphanet journal of rare diseases (2022)
Sirolimus reduced the risk of pneumothorax recurrence in LAM patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • free survival
  • patient reported outcomes